12) Medical Diagnostics
Abstract
Make medical diagnostics ubiquitous and comprehensive against chemical and biological threats (including NTAs, pharmaceutical-based agents, and toxins) by advancing diagnostic innovations; investigating emerging technologies; ensuring medical diagnostics rapid adaptation to emerging threats; harvesting and synergizing the immense volume of diagnostic data; and aligning medical diagnostics capabilities with the FDA pipeline and larger commercial supply chain. This effort will be realigned in FY19 from TM2 (Techbase Med Defense) Chemical Diagnostics, TM2 (Techbase Med Defense) Diagnostic Assays, and TM2 (Techbase Med Defense) Next Generation Diagnostics.
Document Details
- Document Type
- Accomplishment
- Publication Date
- Oct 01, 2019
- Source ID
- 7e92bdfa4791db90c0e416c4fce939e7